Community oncology clinicians’ knowledge, beliefs, and attitudes regarding genomic tumor testing

Authors

Eric Anderson, Maine Medical Center
Alexandra Hinton, Maine Medical Center
Kimberly Murray, Maine Medical Center
Hayley Mandeville, Maine Medical Center
Caitlin Gutheil, Maine Medical Center
Leo Waterston, Maine Medical Center
Lee Lucas, Maine Medical Center
Christine Duarte, Maine Medical Center
Christian Thomas
Susan Miesfeldt, Maine Medical Center
Petra Helbig
Andrey Antov
Jens Rueter
Paul Han, Maine Medical CenterFollow

Document Type

Poster

Publication Date

5-1-2019

Institution/Department

Center for Outcomes Research and Evaluation, Cancer Risk and Prevention Program, Maine Medical Center Cancer Research Institute, Maine Medical Center Research Institute

MeSH Headings

Neoplasms, Genomics

Abstract

Introduction: Genomic tumor testing (GTT) is a new technology that promises to make cancer treatment more precise. However, little is known about clinicians’ knowledge, beliefs, and attitudes regarding GTT, particularly in community oncology settings.

Comments

Lambrew Research Retreat

Acknowledgements: MCGI made possible by funding through the Alfond Foundation

Recommended Citation

Anderson, Eric; Hinton, Alexandra; Murray, Kimberly; Mandeville, Hayley; Gutheil, Caitlin; Waterston, Leo; Lucas, Lee; Duarte, Christine; Thomas, Christian; Miesfeldt, Susan; Helbig, Petra; Antov, Andrey; Rueter, Jens; and Han, Paul, "Community oncology clinicians’ knowledge, beliefs, and attitudes regarding genomic tumor testing" (2019). Maine Medical Center. 693.
https://knowledgeconnection.mainehealth.org/mmc/693